Extrahepatic Cholangiocarcinoma
📧 Sign up to get email alerts when something new happens for Extrahepatic Cholangiocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2016-06-22Clinical Trial Update: Clinical Trial of Adjuvant Chemotherapy Followed by Concurrent Chemoradiotherapy Compared With Adjuvant Chemotherapy Alone in Patients With Gallbladder Carcinoma and Extrahepatic Cholangiocarcinoma [Phase 3]
A Phase 3 clinical trial comparing adjuvant chemotherapy followed by concurrent chemoradiotherapy versus adjuvant chemotherapy alone for gal…
-
CLINICAL_TRIALS trial_result · 2016-04-22Clinical Trial Update: Selumetinib in Treating Patients With Biliary Cancer That Cannot Be Removed By Surgery [Phase 2]
Phase 2 trial of selumetinib in biliary tract cancers, including intrahepatic and extrahepatic cholangiocarcinoma, has completed with result…
-
CLINICAL_TRIALS trial_result · 2016-04-15Clinical Trial Update: MK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by Surgery [Phase 2]
Phase 2 trial evaluating MK-2206 in patients with advanced biliary cancers (including hepatocellular carcinoma and gallbladder/extrahepatic …
-
CLINICAL_TRIALS trial_result · 2016-02-03Clinical Trial Update: Gemcitabine and Cisplatin Plus Sorafenib in Patients With Advanced Biliary Tract Carcinomas Naive to Systemic Therapy [Phase 2]
Phase 2 trial evaluating gemcitabine and cisplatin plus sorafenib in advanced biliary tract cancers (extrahepatic cholangiocarcinoma and gal…
-
CLINICAL_TRIALS trial_result · 2015-08-19Clinical Trial Update: Chemoradiation +Gemcitabine +Continuous 5-FU (Fluorouracil) Followed by High Dose Brachytherapy/Stereotactic Radiation Boost in Locally Advanced Intra/Extrahepatic Cholangiocarcinoma [Phase 2]
Phase 2 trial evaluating chemoradiation with gemcitabine and continuous 5-FU followed by high-dose brachytherapy/SBRT boost in locally advan…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-01-05Clinical Trial Update: Lapatinib in Treating Patients With Locally Advanced or Metastatic Biliary Tract or Liver Cancer That Cannot Be Removed By Surgery [Phase 2]
Phase 2 clinical trial results update on lapatinib for biliary tract and primary liver cancers that are unresectable or unresected; study co…
-
CLINICAL_TRIALS trial_result · 2014-09-12Clinical Trial Update: Radioactive Stents for Treatment of Unresectable Biliary Tract Cancer [NA]
Clinical trial update on radioactive stents for unresectable biliary tract cancers, including intrahepatic cholangiocarcinoma, extrahepatic …
-
CLINICAL_TRIALS withdrawal · 2014-09-09Clinical Trial Update: Selumetinib and Akt Inhibitor MK-2206 in Treating Patients With Refractory or Advanced Gallbladder or Bile Duct Cancer That Cannot Be Removed By Surgery [Phase 2]
A Phase 2 study of selumetinib combined with MK-2206 for refractory or advanced gallbladder and biliary tract cancers has been withdrawn.
-
CLINICAL_TRIALS research · 2014-04-03Clinical Trial Update: VEGF Signaling Promotes Cell Growth and Metastasis in Extrahepatic Cholangiocarcinoma in a VEGF Receptor Mediated Pathway (ECC)
This clinical trial update describes a study examining VEGF signaling as a driver of growth and metastasis in extrahepatic cholangiocarcinom…
-
CLINICAL_TRIALS trial_result · 2014-03-06Clinical Trial Update: Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer [Phase 2]
Phase 2 trial of dolastatin 10 in metastatic or recurrent liver cancer, extrahepatic bile duct cancer, and gallbladder cancer has completed.
-
CLINICAL_TRIALS trial_result · 2014-01-29Clinical Trial Update: Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma [Phase 2]
Phase 2 trial evaluating the combination of sorafenib and erlotinib in locally advanced, unresectable, or metastatic gallbladder cancer or c…
-
CLINICAL_TRIALS withdrawal · 2013-04-04Clinical Trial Update: Stent Placement With or Without Photodynamic Therapy Using Porfimer Sodium as Palliative Treatment in Treating Patients With Stage III or Stage IV Cholangiocarcinoma That Cannot Be Removed By Surgery [Phase 3]
A Phase 3 trial evaluating stent placement with or without photodynamic therapy using porfimer sodium for palliative treatment of unresectab…
-
CLINICAL_TRIALS trial_result · 2013-01-14Clinical Trial Update: S0514 Sorafenib in Treating Patients With Unresectable or Metastatic Gallbladder Cancer or Cholangiocarcinoma [Phase 2]
Phase 2 trial evaluating sorafenib for unresectable or metastatic gallbladder cancer and cholangiocarcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2012-03-08Clinical Trial Update: Blood Proteins in Finding Pancreatic Cancer and Extrahepatic Biliary Tract Cancer
This completed clinical trial evaluated whether certain blood proteins could serve as biomarkers for detecting pancreatic cancer and extrahe…
-
CLINICAL_TRIALS research · 2012-03-08Clinical Trial Update: Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor [Phase 1, Phase 2]
This clinical trial update examines the combination of epirubicin, carboplatin, and capecitabine in patients with unresectable locally advan…
-
CLINICAL_TRIALS trial_result · 2012-03-07Clinical Trial Update: Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer [Phase 1]
A Phase 1 study evaluating the safety and feasibility of combining oxaliplatin, gemcitabine, erlotinib, and radiation therapy in patients wi…
-
CLINICAL_TRIALS trial_result · 2009-02-09Clinical Trial Update: Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile Duct [Phase 2]
Phase 2 clinical trial examining chemotherapy for locally advanced or metastatic pancreatic cancer and extrahepatic bile duct cancer; the st…